Resistance to both insulin and leptin, resulting from PTP1B overexpression, is a characteristic condition found in complex human diseases, such as T2DM and obesity, and can also be an important risk factor for developing metabolic syndrome, cancer and neurodegenerative disorders. Here, INS is linked to obesity disorder.